Cargando…
Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
Chemotherapy-induced mucosal injury of the small intestine may interfere with the enzymes and transporters responsible for the hydrolysis and absorption of dietary carbohydrates causing diarrhoea, abdominal discomfort and pain. The aim of this study was to investigate the association between the con...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071323/ https://www.ncbi.nlm.nih.gov/pubmed/32033152 http://dx.doi.org/10.3390/nu12020407 |
_version_ | 1783506175536398336 |
---|---|
author | Holma, Reetta Laatikainen, Reijo Orell, Helena Joensuu, Heikki Peuhkuri, Katri Poussa, Tuija Korpela, Riitta Österlund, Pia |
author_facet | Holma, Reetta Laatikainen, Reijo Orell, Helena Joensuu, Heikki Peuhkuri, Katri Poussa, Tuija Korpela, Riitta Österlund, Pia |
author_sort | Holma, Reetta |
collection | PubMed |
description | Chemotherapy-induced mucosal injury of the small intestine may interfere with the enzymes and transporters responsible for the hydrolysis and absorption of dietary carbohydrates causing diarrhoea, abdominal discomfort and pain. The aim of this study was to investigate the association between the consumption of foods rich in FODMAPs (fermentable oligo-, di- and monosaccharides and polyols) and gastrointestinal symptoms in patients receiving adjuvant therapy for colorectal cancer. The patients (n = 52) filled in a 4-day food diary at baseline and during therapy and kept a symptom diary. The intakes of FODMAP-rich foods were calculated as portions and the intakes were divided into two consumption categories. Patients with high consumption of FODMAP-rich foods had diarrhoea more frequently than those with low consumption (for lactose-rich foods the odds ratio (OR) was 2.63, P = 0.03; and for other FODMAP-rich foods 1.82, P = 0.20). Patients with high consumption of both lactose-rich and other FODMAP-rich foods had an over 4-fold risk of developing diarrhoea as compared to those with low consumption of both (OR, 4.18; P = 0.02). These results were confirmed in multivariate models. Conclusion: Consumption of lactose-rich foods results in an increased risk of diarrhoea during adjuvant therapy for colorectal cancer, especially when the consumption of other FODMAP-rich foods is also high. |
format | Online Article Text |
id | pubmed-7071323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70713232020-03-19 Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer Holma, Reetta Laatikainen, Reijo Orell, Helena Joensuu, Heikki Peuhkuri, Katri Poussa, Tuija Korpela, Riitta Österlund, Pia Nutrients Article Chemotherapy-induced mucosal injury of the small intestine may interfere with the enzymes and transporters responsible for the hydrolysis and absorption of dietary carbohydrates causing diarrhoea, abdominal discomfort and pain. The aim of this study was to investigate the association between the consumption of foods rich in FODMAPs (fermentable oligo-, di- and monosaccharides and polyols) and gastrointestinal symptoms in patients receiving adjuvant therapy for colorectal cancer. The patients (n = 52) filled in a 4-day food diary at baseline and during therapy and kept a symptom diary. The intakes of FODMAP-rich foods were calculated as portions and the intakes were divided into two consumption categories. Patients with high consumption of FODMAP-rich foods had diarrhoea more frequently than those with low consumption (for lactose-rich foods the odds ratio (OR) was 2.63, P = 0.03; and for other FODMAP-rich foods 1.82, P = 0.20). Patients with high consumption of both lactose-rich and other FODMAP-rich foods had an over 4-fold risk of developing diarrhoea as compared to those with low consumption of both (OR, 4.18; P = 0.02). These results were confirmed in multivariate models. Conclusion: Consumption of lactose-rich foods results in an increased risk of diarrhoea during adjuvant therapy for colorectal cancer, especially when the consumption of other FODMAP-rich foods is also high. MDPI 2020-02-04 /pmc/articles/PMC7071323/ /pubmed/32033152 http://dx.doi.org/10.3390/nu12020407 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Holma, Reetta Laatikainen, Reijo Orell, Helena Joensuu, Heikki Peuhkuri, Katri Poussa, Tuija Korpela, Riitta Österlund, Pia Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title | Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title_full | Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title_fullStr | Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title_full_unstemmed | Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title_short | Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer |
title_sort | consumption of lactose, other fodmaps and diarrhoea during adjuvant 5-fluorouracil chemotherapy for colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071323/ https://www.ncbi.nlm.nih.gov/pubmed/32033152 http://dx.doi.org/10.3390/nu12020407 |
work_keys_str_mv | AT holmareetta consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT laatikainenreijo consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT orellhelena consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT joensuuheikki consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT peuhkurikatri consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT poussatuija consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT korpelariitta consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer AT osterlundpia consumptionoflactoseotherfodmapsanddiarrhoeaduringadjuvant5fluorouracilchemotherapyforcolorectalcancer |